Sole Claudio V, Calvo Felipe A, Serrano Javier, Del Valle Emilio, Rodriguez Marcos, Muñoz-Calero Alberto, Turégano Fernando, García-Sabrido Jose Luis, Garcia-Alfonso Pilar, Peligros Isabel, Rivera Sofia, Deutsch Eric, Alvarez Emilio
Department of Radiation Oncology, Instituto de Radiomedicina, Santiago, Chile; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France; Instituto de Investigacion Sanitaria, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; School of Medicine, Complutense University, Madrid, Spain; Instituto de Investigacion Sanitaria, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Radiother Oncol. 2014 Jul;112(1):52-8. doi: 10.1016/j.radonc.2014.05.012. Epub 2014 Jul 2.
Patients with locally advanced rectal cancer (LARC) have a dismal prognosis. We investigated outcomes and risk factors for locoregional recurrence (LRR) in patients treated with preoperative chemoradiotherapy (CRT), surgery and IOERT.
A total of 335 patients with LARC [⩾cT3 93% and/or cN+ 69%) were studied. In multivariate analyses, risk factors for LRR, IFLR and OFLR were assessed.
Median follow-up was 72.6 months (range, 4-205). In multivariate analysis distal margin distance ⩽10 mm [HR 2.46, p = 0.03], R1 resection [HR 5.06, p = 0.02], tumor regression grade 1-2 [HR 2.63, p = 0.05] and tumor grade 3 [HR 7.79, p < 0.001] were associated with an increased risk of LRR. A risk model was generated to determine a prognostic index for individual patients with LARC.
Overall results after multimodality treatment of LARC are promising. Classification of risk factors for LRR has contributed to propose a prognostic index that could allow us to guide risk-adapted tailored treatment.
局部晚期直肠癌(LARC)患者预后不佳。我们研究了接受术前放化疗(CRT)、手术和术中电子线放疗(IOERT)治疗的患者局部区域复发(LRR)的结局和危险因素。
共研究了335例LARC患者[≥cT3 93%和/或cN+ 69%]。在多变量分析中,评估了LRR、肠壁内复发(IFLR)和肠壁外复发(OFLR)的危险因素。
中位随访时间为72.6个月(范围4 - 205个月)。在多变量分析中,远端切缘距离≤10 mm [风险比(HR)2.46,p = 0.03]、R1切除[HR 5.06,p = 0.02]、肿瘤退缩分级1 - 2级[HR 2.63,p = 0.05]和肿瘤分级3级[HR 7.79,p < 0.001]与LRR风险增加相关。生成了一个风险模型以确定个体LARC患者的预后指数。
LARC多模式治疗后的总体结果令人鼓舞。LRR危险因素的分类有助于提出一个预后指数,使我们能够指导风险适应性个体化治疗。